What does my cholesterol panel mean?
A standard lipid panel gives you four numbers. The conventional targets are: total cholesterol under 200 mg/dL, LDL cholesterol under 100 and ideally lower depending on your risk, HDL cholesterol above 40 in men and above 50 in women, and triglycerides under 150.
Those are the numbers everyone gets. What almost nobody gets explained is that the most important number on that page is calculated rather than measured, and that the two markers which predict risk best are usually not on the page at all.
Your LDL was probably not measured
On most standard panels, LDL cholesterol is not tested directly. It is estimated with a formula using your total cholesterol, HDL, and triglycerides. That estimate works reasonably well in the middle of the range and breaks down at the edges. When triglycerides are high, the formula understates your LDL. At very low LDL values it becomes unreliable in the other direction.
A more robust number sitting right there on your panel is non-HDL cholesterol, which is simply your total cholesterol minus your HDL. It captures every cholesterol-carrying particle that can contribute to plaque, it does not depend on a formula that fails at high triglycerides, and it does not require fasting. If you want one number off a basic panel, non-HDL is a better one than LDL.
The two tests that are almost never ordered
ApoB. Plaque forms when particles carrying cholesterol get into the artery wall. What matters is how many of those particles you have, not only how much cholesterol they are carrying. ApoB counts the particles directly, because each one carries exactly one ApoB molecule.
Why this matters practically: two people can have an identical LDL cholesterol and very different particle counts. This mismatch is common in people with insulin resistance, who tend to carry a large number of small, cholesterol-poor particles. Their LDL reads fine. Their actual particle burden, and their actual risk, is considerably higher. Those are the patients whose heart attack surprises everyone.
Lipoprotein(a). Lp(a) is largely inherited, it is not meaningfully changed by diet or exercise, and it independently raises cardiovascular risk. It affects a substantial minority of people, it explains a good number of the heart attacks that happen in people whose standard panel looked unremarkable, and it needs to be measured only once in your lifetime.
One test, once, that can change your whole risk picture and how aggressively everything else gets managed. It is not on a routine panel. If you have a family history of early heart disease and nobody has ever checked yours, that is worth raising.
Triglycerides and HDL together tell you about insulin
Look at your triglycerides next to your HDL. Rising triglycerides with falling HDL is one of the earliest visible signatures of insulin resistance, and it often appears years before your blood sugar moves at all. A person with a triglyceride of 190 and an HDL of 38 is telling me something about their metabolism, not just about their cholesterol.
This is where a lipid panel and a metabolic panel stop being separate topics. Our page on what your A1c means covers the other half, including why a fasting insulin belongs next to both.
Before treating cholesterol, rule out the causes of it
Not every high cholesterol is primary. An underactive thyroid raises LDL substantially, and correcting the thyroid can correct much of the lipid problem without ever touching a cholesterol medication. Kidney disease, liver disease, uncontrolled diabetes, heavy alcohol use, and several medications also drive lipids up. Checking a TSH before starting long-term therapy is basic, and it gets skipped.
Very high LDL, particularly above 190, or a family history of heart attacks in the forties and fifties, raises the question of familial hypercholesterolemia, an inherited condition that is meaningfully underdiagnosed and that changes the approach for you and for your children.
Where hormones come into it
Lipids shift at menopause, and not favorably. LDL tends to rise and HDL tends to fall through the transition, which is part of why cardiovascular risk in women changes character in these years. A woman who had good numbers her whole life can watch them drift for reasons that have nothing to do with what she is eating.
In men, testosterone therapy can lower HDL modestly, which is one of several reasons lipids are monitored on treatment rather than checked once and forgotten. Neither of these is a reason to avoid hormone therapy. They are reasons the lipid panel stays in the conversation while you are on it.
The number is not the risk
This is the part that changes how the whole page should be read. Your cholesterol on its own does not tell you your risk. Risk is calculated from your lipids together with your age, sex, blood pressure, smoking status, diabetes, and family history. The same LDL means something different in a 38 year old nonsmoker with perfect blood pressure than in a 62 year old diabetic.
And when that calculation lands in the middle, undecided, there is a good tiebreaker: a coronary artery calcium score, a quick low-dose CT that shows whether plaque has actually formed in your arteries. A score of zero is genuinely reassuring. A high score in someone with average-looking numbers changes the plan immediately. It answers the question the blood test can only estimate.
Practical points about the draw
Fasting is no longer required for routine lipid screening. Current guidelines accept a nonfasting panel for most purposes, with a fasting repeat if triglycerides come back high. Acute illness, recent infection, and pregnancy all distort lipids temporarily, so a panel drawn during any of those is not your baseline.
| What we measure | Conventional target | Why it matters |
|---|---|---|
| Total cholesterol | Under 200 mg/dL | A rough summary; too crude to act on alone |
| LDL cholesterol | Under 100, lower with higher risk | Usually calculated, not measured; unreliable when triglycerides are high |
| HDL cholesterol | Above 40 men, above 50 women | Low HDL flags risk; raising it with drugs has not shown benefit |
| Triglycerides | Under 150 | Rises early in insulin resistance; over 500 is a pancreatitis risk |
| Non-HDL cholesterol | Roughly 30 above your LDL goal | Already on your panel, more reliable than LDL, no fasting needed |
| ApoB | Risk dependent | Counts atherogenic particles; catches risk a normal LDL hides |
| Lipoprotein(a) | Measured once in a lifetime | Inherited, independent risk factor, almost never ordered |
| TSH, A1c, fasting insulin, kidney and liver panel | See our related pages | Identifies the correctable causes before committing to lifelong treatment |
This page is education, not your interpretation
Everything above explains what a lipid panel measures and where the standard version falls short. It is not a reading of your result and it is not a treatment recommendation. What your numbers call for depends on your overall risk, your other labs, your family history, and what has been ruled out.
The next step
If you have a lipid panel and you were told it was borderline, or told it was fine but you have a family history that worries you, bring it in. A physician lab review means we go through the results you already paid for, I tell you what your non-HDL is, whether ApoB and Lp(a) should be added, whether anything correctable is driving the numbers, and where you actually sit on risk rather than on a single line of a report.
To Health and Wellness, Dr. Tallman
References
- Circulation, 2018 — ACC/AHA guideline on the management of blood cholesterol.
- European Heart Journal, 2016 — EAS/EFLM consensus on nonfasting lipid measurement.
- Journal of the American College of Cardiology — ApoB and discordance with LDL cholesterol in cardiovascular risk prediction.
- European Heart Journal, 2022 — European Atherosclerosis Society consensus statement on lipoprotein(a).
- Journal of the American College of Cardiology — coronary artery calcium scoring for risk refinement in intermediate-risk adults.